Package 62135-669-90

Brand: quinapril and hydrochlorothiazide

Generic: quinapril and hydrochlorothiazide
NDC Package

Package Facts

Identity

Package NDC 62135-669-90
Digits Only 6213566990
Product NDC 62135-669
Description

90 TABLET in 1 BOTTLE (62135-669-90)

Marketing

Marketing Status
Marketed Since 2023-12-05
Brand quinapril and hydrochlorothiazide
Generic quinapril and hydrochlorothiazide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0c3f4504-d57e-aa79-e063-6294a90ad5b8", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0362135669904", "0362135667900", "0362135668907"], "unii": ["0J48LPH2TH", "33067B3N2M"], "rxcui": ["310796", "310797", "310809"], "spl_set_id": ["2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (62135-669-90)", "package_ndc": "62135-669-90", "marketing_start_date": "20231205"}], "brand_name": "Quinapril and Hydrochlorothiazide", "product_id": "62135-669_0c3f4504-d57e-aa79-e063-6294a90ad5b8", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "62135-669", "generic_name": "Quinapril and Hydrochlorothiazide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Quinapril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "QUINAPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA076374", "marketing_category": "ANDA", "marketing_start_date": "20040331", "listing_expiration_date": "20261231"}